SEC Form 4
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION | ||
Washington, D.C. 20549 | OMB APPROVAL | |
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP | ||
OMB Number: | 3235-0287 | |
Estimated average burden | ||
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 | hours per response: | 0.5 |
or Section 30(h) of the Investment Company Act of 1940 |
1. Name and Address of Reporting Person* | 2. Issuer Name and Ticker or Trading Symbol | 5. Relationship of Reporting Person(s) to Issuer | ||||||||||||||||||||||||||||||||||
WEST JEFFREY N | MAGELLAN HEALTH INC[ MGLN ] | (Check all applicable) | ||||||||||||||||||||||||||||||||||
Director | 10% Owner | |||||||||||||||||||||||||||||||||||
X | Officer (give title | Other (specify | ||||||||||||||||||||||||||||||||||
(Last) | (First) | (Middle) | 3. Date of Earliest Transaction (Month/Day/Year) | below) | below) | |||||||||||||||||||||||||||||||
SVP & Controller | ||||||||||||||||||||||||||||||||||||
14100 MAGELLAN PLAZA | 03/05/2020 | |||||||||||||||||||||||||||||||||||
(Street) | 4. If Amendment, Date of Original Filed (Month/Day/Year) | 6. Individual or Joint/Group Filing (Check Applicable | ||||||||||||||||||||||||||||||||||
Line) | ||||||||||||||||||||||||||||||||||||
MARYLAND | ||||||||||||||||||||||||||||||||||||
MO | 63043 | X Form filed by One Reporting Person | ||||||||||||||||||||||||||||||||||
HEIGHTS | ||||||||||||||||||||||||||||||||||||
Form filed by More than One Reporting | ||||||||||||||||||||||||||||||||||||
Person | ||||||||||||||||||||||||||||||||||||
(City) | (State) | (Zip) | ||||||||||||||||||||||||||||||||||
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||||||||||||||||||||||||||||
1. Title of Security (Instr. 3) | 2. Transaction | 2A. Deemed | 3. | 4. Securities Acquired (A) or | 5. Amount of | 6. Ownership | 7. Nature | |||||||||||||||||||||||||||||
Date | Execution Date, | Transaction | Disposed Of (D) (Instr. 3, 4 and 5) | Securities | Form: Direct | of Indirect | ||||||||||||||||||||||||||||||
(Month/Day/Year) | if any | Code (Instr. | Beneficially | (D) or Indirect | Beneficial | |||||||||||||||||||||||||||||||
(Month/Day/Year) | 8) | Owned Following | (I) (Instr. 4) | Ownership | ||||||||||||||||||||||||||||||||
Reported | (Instr. 4) | |||||||||||||||||||||||||||||||||||
Code | V | Amount | (A) or | Price | Transaction(s) | |||||||||||||||||||||||||||||||
(D) | (Instr. 3 and 4) | |||||||||||||||||||||||||||||||||||
Ordinary Common Stock, $0.01 par value | 03/05/2020 | M(1) | 839 | A | $0.00(2) | 22,240 | D | |||||||||||||||||||||||||||||
Ordinary Common Stock, $0.01 par value | 03/05/2020 | F(3) | 244 | D | $60.03(4) | 21,996 | D | |||||||||||||||||||||||||||||
Ordinary Common Stock, $0.01 par value | 03/05/2020 | M(5) | 1,448 | A | $0.00(2) | 23,444 | D | |||||||||||||||||||||||||||||
Ordinary Common Stock, $0.01 par value | 03/05/2020 | F(3) | 429 | D | $60.03(4) | 23,015 | D | |||||||||||||||||||||||||||||
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||||||||||||||||||||||||||||
(e.g., puts, calls, warrants, options, convertible securities) | ||||||||||||||||||||||||||||||||||||
1. Title of | 2. | 3. Transaction | 3A. Deemed | 4. | 5. Number | 6. Date Exercisable and | 7. Title and | 8. Price of | 9. Number of | 10. | 11. Nature | |||||||||||||||||||||||||
Derivative | Conversion | Date | Execution Date, | Transaction | of | Expiration Date | Amount of | Derivative | derivative | Ownership | of Indirect | |||||||||||||||||||||||||
Security | or Exercise | (Month/Day/Year) | if any | Code (Instr. | Derivative | (Month/Day/Year) | Securities | Security | Securities | Form: | Beneficial | |||||||||||||||||||||||||
(Instr. 3) | Price of | (Month/Day/Year) | 8) | Securities | Underlying | (Instr. 5) | Beneficially | Direct (D) | Ownership | |||||||||||||||||||||||||||
Derivative | Acquired | Derivative Security | Owned | or Indirect | (Instr. 4) | |||||||||||||||||||||||||||||||
Security | (A) or | (Instr. 3 and 4) | Following | (I) (Instr. 4) | ||||||||||||||||||||||||||||||||
Disposed | Reported | |||||||||||||||||||||||||||||||||||
of (D) | Transaction(s) | |||||||||||||||||||||||||||||||||||
(Instr. 3, 4 | (Instr. 4) | |||||||||||||||||||||||||||||||||||
and 5) | ||||||||||||||||||||||||||||||||||||
Amount | ||||||||||||||||||||||||||||||||||||
or | ||||||||||||||||||||||||||||||||||||
Number | ||||||||||||||||||||||||||||||||||||
Date | Expiration | of | ||||||||||||||||||||||||||||||||||
Code | V | (A) | (D) | Exercisable | Date | Title | Shares | |||||||||||||||||||||||||||||
Restricted | $0.00(2) | 03/05/2020 | M(1) | 839 | 03/05/2020 | (2) | Common | 839 | $0.00(2) | 839 | D | |||||||||||||||||||||||||
Stock | Stock | |||||||||||||||||||||||||||||||||||
Restricted | $0.00(2) | M(5) | (2) | Common | 1,448 | $0.00(2) | ||||||||||||||||||||||||||||||
Stock | 03/05/2020 | 1,448 | 03/05/2020 | 2,894 | D | |||||||||||||||||||||||||||||||
Units | Stock | |||||||||||||||||||||||||||||||||||
Explanation of Responses:
- This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on March 5, 2018. Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock.
- Not applicable.
- Represents the portion of shares withheld by the Company in order to pay taxes.
- Closing price on NASDAQ on March 5, 2020.
- This transaction was effectuated by a one-third vesting of the Restricted Stock Unit Award granted on March 5, 2019. Each Restricted Stock Unit represents a contingent right to receive one share of Magellan common stock.
Remarks:
/s/ Jeffrey N. West | 03/09/2020 | |
** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
-
Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Attachments
- Original document
- Permalink
Disclaimer
Magellan Health Inc. published this content on 09 March 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 March 2020 17:57:01 UTC